-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
AEON Biopharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2021 to 2024.
- AEON Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was $2.08M.
- AEON Biopharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was $42M.
- AEON Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $42M.
- AEON Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$52.6M, a 741% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)